Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Perioperative Infusion of 6 % Hydroxyethyl Starch 130/0.4 in an Isotonic Electrolyte Solution (VolulyteTM) vs. 5% HSA as Volume Replacement Therapy During Cardiac Surgery for Adult Patients

NCT01553617 is registered in ClinicalTrials.gov with Fresenius Kabi as lead sponsor.

NCT NCT01553617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01553617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Perioperative Infusion of 6 % Hydroxyethyl Starch 130/0.4 in an Isotonic Electrolyte Solution (VolulyteTM) vs. 5% HSA as Volume Replacement Therapy During Cardiac Surgery for Adult Patients
Lead sponsor
Fresenius Kabi
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2012
Completion date
January 31, 2014
Enrollment
133 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

heart; dysfunction postoperative, cardiac surgery